Clinical Trial Update: SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SOX chemotherapy combined with sintilimab and trastuzumab versus SOX alone in perioperative treatment of HER2-positive locally advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric or Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• SOX (SOX)
• Sintilimab (sintilimab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Aiping Zhou | Conditions: HER2-positive, Locally Advanced Solid Tumor | Phase 2 | Status: UNKNOWN